Android app Apple app link

Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options

By Yahoo! Finance   |   1 week ago
Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options

Hims & Hers stock fell after announcing new weight-loss drug offerings, including Zepbound and a generic GLP-1 medication. The company faces challenges as it adjusts its drug offerings due to FDA regulations and pricing concerns.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.